Synonyms: ARRY-440 | ARRY440 | PF-07799933 | PF07799933
Compound class:
Synthetic organic
Comment: The chemical structure for claturafenib was derived from WHO proposed INN list 132 (Feb 2025), in which it is listed as a B-Raf (BRAF) inhibitor, with antineoplastic potential. This generated a SMILES match via PubChem to a compound claimed in patent WO2021250521A1 (Array Biopharma; Pfizer acquisition) [1]. This is the INN for Pfizer's clinical candidate PF-07799933 (formerly ARRY-440) whose structure is presented in supplementary figure S2 [2]. PF-07799933 is an orthosteric, pan-mutant BRAF inhibitor that can cross the blood-brain barrier. It disrupts BRAF-containing dimers, including those containing V600 and non-V600 BRAF mutants but does not alter formation of CRAF homodimers and ARAF-containing dimers. PF-07799933 may also alter BRAF-MEK complex formation.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel